Want to see KCDMY full AI Analyst Report?
KCDMY Stock Chart & Stats
$11.37
$0.11(0.97%)
At close: 4:00 PM EDT
$11.37
$0.11(0.97%)
Day’s Range― - ―
52-Week Range$9.21 - $12.55
Previous CloseN/A
Volume26.82K
Average Volume (3M)6.96K
Market Cap
$6.91B
Enterprise Value$7.36K
Total Cash (Recent Filing)$19.59B
Total Debt (Recent Filing)$32.86B
Price to Earnings (P/E)14.8
Beta0.18
Next Earnings
Oct 20, 2026EPS Estimate
0.18Next Dividend Ex-DateN/A
Dividend Yield5.04%
Share Statistics
EPS (TTM)13.25
Shares Outstanding312,725,340
10 Day Avg. Volume0
30 Day Avg. Volume6,964
Financial Highlights & Ratios
PEG Ratio-2.43
Price to Book (P/B)15.97
Price to Sales (P/S)2.23
P/FCF Ratio19.02
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.77
Revenue Forecast (FY)$3.35B
Bulls Say, Bears Say
Bulls Say
High And Stable ProfitabilitySustained high margins, shown by strong gross and EBITDA margins, reflect durable pricing power, cost control and product mix advantages in tissue and personal-care categories. Persistent operating profitability supports reinvestment, dividend funding and resilience to moderate input cost swings.
Strong Free Cash Flow ConversionHigh FCF conversion and year-over-year FCF growth indicate strong cash generation from core operations, enabling capital allocation for dividends, capex, strategic initiatives and potential deleveraging. This cash durability underpins financial flexibility over the medium term.
Recurring Demand And Volume RecoveryVolume-driven revenue gains in core consumer categories show resilient, high-frequency demand and effective commercial execution. Durable consumer staples consumption, supported by innovation and multi-tier strategy, provides a stable revenue base and reduces reliance on one-off price effects.
Bears Say
Elevated LeverageA sharp rise in leverage materially thins the equity cushion and raises refinancing and solvency risk. High debt amplifies earnings volatility and limits strategic flexibility for M&A or buybacks, making balance-sheet repair and interest-cost management priorities over coming months.
Rising SG&A And Promotional PressureEscalating SG&A and persistent promotional activity erode margin resilience and can outpace cost savings. Elevated distribution, technology and compensation costs require sustained discipline; otherwise they may compress operating margins even if gross margins hold.
Segment Headwinds: Away‑from‑Home & ExportsWeakness in Away‑from‑Home and exports reduces revenue diversification and exposes the company to timing, distributor and macro swings. If recoveries lag, consolidated growth could be uneven despite consumer-products strength, pressuring medium-term top‑line momentum.
Kimberly-Clark de Mexico SAB de CV News
KCDMY FAQ
What was Kimberly-Clark de Mexico SAB de CV’s price range in the past 12 months?
Kimberly-Clark de Mexico SAB de CV lowest stock price was $9.21 and its highest was $12.55 in the past 12 months.
What is Kimberly-Clark de Mexico SAB de CV’s market cap?
Kimberly-Clark de Mexico SAB de CV’s market cap is $6.91B.
When is Kimberly-Clark de Mexico SAB de CV’s upcoming earnings report date?
Kimberly-Clark de Mexico SAB de CV’s upcoming earnings report date is Oct 20, 2026 which is in 65 days.
How were Kimberly-Clark de Mexico SAB de CV’s earnings last quarter?
Kimberly-Clark de Mexico SAB de CV released its earnings results on Jul 21, 2026. The company reported $0.195 earnings per share for the quarter, missing the consensus estimate of $0.2 by -$0.005.
Is Kimberly-Clark de Mexico SAB de CV overvalued?
According to Wall Street analysts Kimberly-Clark de Mexico SAB de CV’s price is currently Overvalued.
Does Kimberly-Clark de Mexico SAB de CV pay dividends?
Kimberly-Clark de Mexico SAB de CV pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 5.04%. See more information on Kimberly-Clark de Mexico SAB de CV dividends here
What is Kimberly-Clark de Mexico SAB de CV’s EPS estimate?
Kimberly-Clark de Mexico SAB de CV’s EPS estimate is 0.18.
How many shares outstanding does Kimberly-Clark de Mexico SAB de CV have?
Kimberly-Clark de Mexico SAB de CV has 312,725,340 shares outstanding.
What happened to Kimberly-Clark de Mexico SAB de CV’s price movement after its last earnings report?
Kimberly-Clark de Mexico SAB de CV reported an EPS of $0.195 in its last earnings report, missing expectations of $0.2. Following the earnings report the stock price went up 1.178%.
Which hedge fund is a major shareholder of Kimberly-Clark de Mexico SAB de CV?
Currently, no hedge funds are holding shares in KCDMY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kimberly-Clark de Mexico SAB de CV Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
56.99%
12-Months-Change
Fundamentals
Return on Equity
5.04%
Trailing 12-Months
Asset Growth
28.77%
Trailing 12-Months
Company Description
Kimberly-Clark de Mexico SAB de CV
Kimberly-Clark de México, S. A. B. de C. V., through its subsidiaries, manufactures and distributes a wide array of disposable consumer goods for everyday use across Mexico. The company's diverse product offering spans several categories: infant care, featuring diapers, training pants, swim diapers, wet wipes, shampoos, soaps, and feeding items; beauty products, including various bar and liquid soaps, micellar water, and makeup removal wipes; adult care products like protective underwear, pads, and prefolded items; household paper goods such as toilet paper, napkins, facial tissues, and paper towels; and feminine hygiene essentials like pads, panty liners, tampons, and intimate wipes. Additionally, it supplies professional and industrial clients with dispensers, jumbo roll toilet papers, various towels, antibacterial gel, disinfecting spray, facemasks, and specialized cleaning cloths. These offerings are sold predominantly under popular brands including Huggies, KleenBebe, Pull-Ups, Evenflo, Kleenex, Kotex, Depend, Cottonelle, Pétalo, Suavel, Vogue, Sanitas, Marli y Kimlark, Jabón Escudo Antibacterial, and Jabones Kleenex. The company also engages in exporting its products. Kimberly-Clark de México, S. A. B. de C. V. was founded in 1925 and operates from its base in Mexico City, Mexico.
KCDMY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reported multiple clear positives: a record quarter of revenue, volume-driven consumer-products growth, strong margin and profitability expansion, meaningful structural cost savings (MXN 450 million), and solid balance-sheet metrics (cash MXN 19.6 billion; net debt/EBITDA 0.9x). Management also highlighted strategic progress (innovation pipeline, private-label traction, potential Kenvue transaction) and reiterated margin discipline. Offsetting these positives were several near-term headwinds: a weak Away from Home segment (-5.1%), exports decline (-11.1%), rising SG&A (+11.5%), and expected near-term raw-material/derivative cost pressures and higher financing costs. Management expects Q3 to be more challenging on costs and pricing but anticipates margins to remain within target range and improvement into Q4 as input costs normalize. Overall, the positive operational performance, structural savings, and strong liquidity/leverage metrics outweigh the near-term challenges, while management has clear plans to address the headwinds.View all KCDMY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
99.87% Public Companies and
Individual Investors